Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Journal of Clinical Medicine|May 27, 2023
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel DiseaseXavier Roblin, Gérard Duru, Konstantinos Papamichael, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 8, 2023
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre studySophie Vieujean, David Laharie, Anthony Buisson, et al.Journal of Crohn'S & Colitis|July 2, 2016
Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T CellsGilles Boschetti, Reem Kanjarawi, Emilie Bardel, et al.Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.Alimentary Pharmacology & Therapeutics|March 1, 2022
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's diseaseXavier Roblin, Pauline Veyrard, Laetitia Bastide, et al.Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.Gastrointestinal Endoscopy|March 9, 2019
Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot studyJulie Auzoux, Gilles Boschetti, Benjamin Anon, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 25, 2024
An audit of central venous catheter insertion and management practices in two French university hospitalsNagham Khanafer, Sophie Gardes, Nathalie De-Santis, et al.Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.Inflammatory Bowel Diseases|December 22, 2016
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's DiseaseXavier Roblin, Gerard Duru, Nicolas Williet, et al.Pageof 6